Stay updated on ENABLE Study: Lanadelumab in HAE Clinical Trial
Sign up to get notified when there's something new on the ENABLE Study: Lanadelumab in HAE Clinical Trial page.

Latest updates to the ENABLE Study: Lanadelumab in HAE Clinical Trial page
- Check3 days agoChange DetectedThe study record versions now show Revision: v3.3.4 added and Revision: v3.3.3 removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedRevision: v3.3.3 was added to the record history, and the footer now omits 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2'; these are minor site-maintenance updates that do not affect study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check53 days agoChange DetectedThe Study Record Versions now show a new Revision: v3.3.2 and the removal of Revision: v3.2.0.SummaryDifference0.1%

- Check60 days agoChange DetectedDeleted the government funding and operating status notice directing users to cc.nih.gov and opm.gov.SummaryDifference0.7%

- Check74 days agoChange Detected- Added a new version entry dated 2025-08-29 to the Record History, reflecting updated study status and related sections.SummaryDifference0.1%

- Check103 days agoChange DetectedSummary: The page adds a government-operating-status notice and a v3.2.0 release tag, while removing the v3.1.0 tag. The new notice is the significant change, signaling updated operating status and potential transaction delays.SummaryDifference12%

Stay in the know with updates to ENABLE Study: Lanadelumab in HAE Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ENABLE Study: Lanadelumab in HAE Clinical Trial page.